Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry
European Psychiatry June 23, 2026 Maximilian Preiß, Valentin Popper, Luna Helene Charlotte Faber et al.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.